Natera-JPM-Slides-2026-Final.pdf

1、J.P.Morgan Healthcare ConferenceJanuary 13,2026Natera,Inc.Investor presentation12Confidential.Not for reproduction or further distribution.Thispresentationcontainsforward-lookingstatements underthemeaningofthePrivateSecuritiesLitigationReform Actof1995.Allstatements otherthanstatements ofhistoricalf

2、acts containedinthispresentation,includingstatements regardingourmarketopportunity,ouranticipatedproductsandlaunchschedules,ourreimbursement coverageandourproductcosts,ourcommercial and strategic partnershipsandpotentialacquisitions,ouruser experience,ourclinicaltrialsandstudies,ourstrategies,ourgoa

3、lsandgeneralbusinessandmarketconditions,and our preliminary financial results for the fourth quarter and fiscal year ended December 31,2025,areforward-lookingstatements.The preliminary financial results for the fourth quarter and fiscal year ended December 31,2025 have not been audited by our indepe

4、ndent registered public accounting firm and are based on managements initial review of our operations and results for the completed fiscal year.These preliminary financial results are subject to revisions based upon our year-end closing procedures,final adjustments and the audit to be conducted by o

5、ur independent registered public accounting firm.As a result,our actual financial results for the fourth quarter and fiscal year ended December 31,2025 may differ materially from these preliminary results.In addition,these preliminary financial results are not a comprehensive statement of our financ

6、ial results for the fiscal year ended December 31,2025,and should not be viewed as a substitute for full,audited financial statements prepared in accordance with generally accepted accounting principles.These forward-looking statements are subject to known and unknown risks and uncertainties that ma